Prana’s Research Was Presented At International Conference On Alzheimer’s Disease On July 14

Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), Head of Research, Assoc. Prof. Robert Cherny, presented new data on PBT2, the Company's lead compound in development for Alzheimer's Disease on July 14th at the prestigious International Conference of Alzheimer's Disease (ICAD) in Honolulu...